M.E.M. Kuilman

431 total citations
10 papers, 333 citations indexed

About

M.E.M. Kuilman is a scholar working on Animal Science and Zoology, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, M.E.M. Kuilman has authored 10 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Animal Science and Zoology, 3 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Pharmacology. Recurrent topics in M.E.M. Kuilman's work include Hormonal and reproductive studies (3 papers), Pharmacological Effects and Assays (3 papers) and Down syndrome and intellectual disability research (2 papers). M.E.M. Kuilman is often cited by papers focused on Hormonal and reproductive studies (3 papers), Pharmacological Effects and Assays (3 papers) and Down syndrome and intellectual disability research (2 papers). M.E.M. Kuilman collaborates with scholars based in Netherlands, Belgium and United States. M.E.M. Kuilman's co-authors include R.F.M. Maas, Johanna Fink‐Gremmels, Frank E. Visser, J. Overweg, A.C. van Huffelen, Albert P. Aldenkamp, Michelle W. J. Versleijen, Elbert A.J. Joosten, P.R. Bär and Evert C. A. Kaal and has published in prestigious journals such as Journal of Neurochemistry, The Analyst and Journal of Chromatography B.

In The Last Decade

M.E.M. Kuilman

10 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.E.M. Kuilman Netherlands 6 118 79 62 55 55 10 333
Renata Ramalho Portugal 12 40 0.3× 43 0.5× 17 0.3× 5 0.1× 9 0.2× 38 432
Pamela L. Moriearty United States 12 141 1.2× 27 0.3× 56 0.9× 12 0.2× 5 0.1× 35 531
Fátima Brant Brazil 13 120 1.0× 17 0.2× 13 0.2× 13 0.2× 4 0.1× 20 399
John R. Sheedy Australia 10 69 0.6× 22 0.3× 97 1.6× 20 0.4× 2 0.0× 16 439
Eduardo Vázquez-Valls Mexico 12 18 0.2× 36 0.5× 18 0.3× 17 0.3× 6 0.1× 28 441
Roberto Ruíz Spain 6 61 0.5× 21 0.3× 21 0.3× 6 0.1× 9 0.2× 8 358
Florian Astelbauer Austria 7 41 0.3× 13 0.2× 123 2.0× 16 0.3× 2 0.0× 7 457
Defu Zhang China 11 225 1.9× 32 0.4× 20 0.3× 3 0.1× 11 0.2× 29 369
Prabhati Ray United States 16 68 0.6× 149 1.9× 13 0.2× 76 1.4× 37 521
Zhengyu Lu China 7 11 0.1× 43 0.5× 20 0.3× 62 1.1× 2 0.0× 15 372

Countries citing papers authored by M.E.M. Kuilman

Since Specialization
Citations

This map shows the geographic impact of M.E.M. Kuilman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.E.M. Kuilman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.E.M. Kuilman more than expected).

Fields of papers citing papers by M.E.M. Kuilman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.E.M. Kuilman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.E.M. Kuilman. The network helps show where M.E.M. Kuilman may publish in the future.

Co-authorship network of co-authors of M.E.M. Kuilman

This figure shows the co-authorship network connecting the top 25 collaborators of M.E.M. Kuilman. A scholar is included among the top collaborators of M.E.M. Kuilman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.E.M. Kuilman. M.E.M. Kuilman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Visser, Frank E., Albert P. Aldenkamp, Alexander C. van Huffelen, et al.. (2004). Early Signs of Dementia Checklist 1997. Open Scholarship Institutional Repository (Washington University in St. Louis). 89. 2 indexed citations
2.
Kuilman, M.E.M., R.F.M. Maas, & Johanna Fink‐Gremmels. (2000). Cytochrome P450-mediated metabolism and cytotoxicity of aflatoxin B1 in bovine hepatocytes. Toxicology in Vitro. 14(4). 321–327. 83 indexed citations
3.
Kuilman, M.E.M., et al.. (2000). Inhibition of aflatoxin M1production by bovine hepatocytes after intervention with oltipraz. Veterinary Quarterly. 22(1). 30–35. 11 indexed citations
4.
Kaal, Evert C. A., Angela S. Vlug, Michelle W. J. Versleijen, et al.. (2000). Chronic Mitochondrial Inhibition Induces Selective Motoneuron Death In Vitro: A New Model for Amyotrophic Lateral Sclerosis. Journal of Neurochemistry. 74(3). 1158–1165. 69 indexed citations
5.
Kuilman, M.E.M., R.F.M. Maas, Renger F. Witkamp, et al.. (1999). 17alpha-ethyl-5beta-estrane-3alpha, 17beta-diol, a biological marker for the abuse of norethandrolone and ethylestrenol in slaughter cattle. Journal of Chromatography B. 728. 217. 2 indexed citations
6.
Kuilman, M.E.M., R.F.M. Maas, Renger F. Witkamp, et al.. (1999). 17α-Ethyl-5β-estrane-3α,17β-diol, a biological marker for the abuse of norethandrolone and ethylestrenol in slaughter cattle. Journal of Chromatography B Biomedical Sciences and Applications. 728(2). 217–232. 6 indexed citations
7.
Raus, J., Dirk Vanderzande, J. Gelan, et al.. (1998). In vitro liver models are important tools to monitor the abuse of anabolic steroids in cattle†. The Analyst. 123(12). 2453–2456. 4 indexed citations
8.
Visser, Frank E., et al.. (1997). Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome.. PubMed. 101(4). 400–12. 137 indexed citations
9.
Visser, Frank E., M.E.M. Kuilman, J. Oosting, et al.. (1996). Use of electroencephalography to detect Alzheimer's disease in Down's syndrome. Acta Neurologica Scandinavica. 94(2). 97–103. 17 indexed citations
10.
Visser, Frank E. & M.E.M. Kuilman. (1990). [Dementia symptoms in Down's syndrome in a residentially treated group of mentally handicapped].. PubMed. 134(23). 1141–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026